首页> 外文期刊>Journal of Surgical Oncology >Usefulness of a modified inflammation-based prognostic system for predicting postoperative mortality of patients undergoing surgery for primary hepatocellular carcinoma.
【24h】

Usefulness of a modified inflammation-based prognostic system for predicting postoperative mortality of patients undergoing surgery for primary hepatocellular carcinoma.

机译:改良的基于炎症的预后系统可用于预测原发性肝细胞癌手术患者的术后死亡率。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To assess and compare the predictive values of the hepatic Glasgow Prognostic Score (hGPS) and Cancer of the Liver Italian Program (CLIP) score in patients undergoing surgery for primary hepatocellular carcinoma (HCC). METHODS: The hGPS was calculated as follows: patients with an elevated level of C-reactive protein (CRP) (>0.3 mg/dl) were allocated a hGPS of 1 or 2 depending on the absence or presence of hypoalbuminemia (<3.5 g/dl), and patients without an elevation of the CRP level (/= 2) (P = 0.021). Comparative analysis using these two factors showed that the hGPS was predictively superior to the CLIP score (P = 0.033). CONCLUSIONS: The hGPS is able to divide patients undergoing surgery for primary HCC into three independent groups, and is considered to be an important factor predictive of postoperative mortality in such patients.
机译:目的:评估和比较原发性肝细胞癌(HCC)手术患者的肝格拉斯哥预后评分(hGPS)和意大利肝癌计划(CLIP)评分的预测值。方法:hGPS的计算如下:C反应蛋白(CRP)水平升高(> 0.3 mg / dl)的患者根据是否存在低白蛋白血症(<3.5 g / l)被分配1或2的hGPS。 dl),而CRP水平未升高( / = 2)(P = 0.021)。使用这两个因素进行的比较分析显示,hGPS在预测性上优于CLIP评分(P = 0.033)。结论:hGPS能够将接受原发性肝癌手术的患者分为三个独立的组,并且被认为是预测此类患者术后死亡率的重要因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号